Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...

"Sickle cell largely affects patients from African and African-Caribbean backgrounds, who are less likely to have a matching stem cell donor, and this community has been waiting years for a new ...

Dr. Preethi Marri discusses Sickle Cell Disease and summer safety ...

As World Sickle Cell Awareness Day on June 19 draws near, a collaborative of 47 community organizations and medical providers ...

Madron Gallery presents Palette and Palate, an exhibition celebrating Chicago, its artists, and one of the city’s most unique and beloved artist-run spaces of the mid-twentieth century, Riccardo’s ...